Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Nature Communications|October 27, 2019
Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemiaYasutaka Hayashi, Susumu Goyama, XiaoXiao Liu, et al.
Blood Advances|April 2, 2026
IL-6-driven POU2AF1 and ELL2 are key regulators of multiple myeloma-distinct transcriptional and splicing programsYasuyo Ohguchi, Masahiko Ajiro, Daisuke Ogiya, et al.
Blood|March 29, 2020
Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in miceKotaro Shide, Takuro Kameda, Ayako Kamiunten, et al.
Nature Communications|June 24, 2014
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformationGoro Sashida, Hironori Harada, Hirotaka Matsui, et al.
Genomics Data|October 21, 2015
Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasmsTakuro Kameda, Kotaro Shide, Takumi Yamaji, et al.
Blood|October 21, 2011
The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutationsGang Huang, Xinghui Zhao, Lan Wang, et al.
Nature Communications|December 19, 2014
Histone acetylation mediated by Brd1 is crucial for Cd8 gene activation during early thymocyte developmentYuta Mishima, Changshan Wang, Satoru Miyagi, et al.
The Journal of Experimental Medicine|November 13, 2013
Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disordersTomoya Muto, Goro Sashida, Motohiko Oshima, et al.
Blood Neoplasia|September 15, 2025
TYK2 is essential for the therapeutic effect of IFN-α in Jak2V617F-induced murine myeloproliferative neoplasmsYuki Tahira, Kotaro Shide, Takuro Kameda, et al.
Blood|June 29, 2012
Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cellsYue Zhang, Xiaomei Yan, Goro Sashida, et al.
Pageof 9